While vapor testing methods already exist for tobacco e-cigarettes, this is uncharted territory for the cannabis sector. So how can companies adapt?
Jointly issued on September 14, 2021, the notices say that the popular derivative of THC comes with “serious health risks” and that those selling delta-8 products should provide information about the compound’s psychoactive qualities.
Dispensary staff routinely advise medical cannabis consumers about safe storage and common adverse events, but few counsel patients about cannabis use disorder or other risks, according to new research.
This new advice from the British Medical Journal applies to adults and children living with moderate-to-severe levels of chronic pain.
Delta-8 THC is more popular than ever. But one cannabis lab in Massachusetts has stopped testing products containing the THC variant all together. Analytical Cannabis caught up with its founder to find out more.
In a talk at the Analytical Cannabis Expo West Online 2021, Dr Julie Martellini, science operations manager at Massachusetts’ MCR Labs, walked attendees through how the Framingham-based lab adapted to the new challenges presented by the Covid-19 pandemic.
Robert Thomas, a leading heavy metals expert in the cannabis testing sector and principle of the consulting company Scientific Solutions, explains just how inductively coupled plasma-mass-spectrometry (ICP-MS) can lower the regulatory demands of cannabis testing to better understand the link between lead toxicity and human disease.